BIL vs SCHA
SPDR Bloomberg 1-3 Month T-Bill ETF vs Schwab US Small-Cap ETF
BIL$91.50
SPDR Bloomberg 1-3 Month T-Bill ETF
Ultra-short T-Bills, cash-equivalent.
Expense: 0.14%Yield: 3.66%
SCHA$33.55
Schwab US Small-Cap ETF
US small-cap equities.
Expense: 0.03%Yield: 1.12%
Quick take
- • SCHA has the lower expense ratio at 0.03% vs 0.14% for BIL.
- • BIL pays a higher dividend yield (3.66%).
Side-by-side metrics
| Metric | BIL | SCHA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.14% | 0.03% |
Dividend yield Trailing 12-month yield. | 3.66% | 1.12% |
AUM Assets under management — bigger funds are typically more liquid. | $48.51B | $22.04B |
YTD return | 3.12% | 18.09% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.00 | 1.23 |
P/E ratio | — | 16.37 |
Last price | $91.50 | $33.55 |
Inception | — | — |
Issuer | State Street | Schwab |
BIL top holdings
Holdings data unavailable for BIL.
SCHA top holdings
Top holdings · SCHA
| HALO | Halozyme Therapeutics Inc | 0.36% |
| GKOS | Glaukos Corp | 0.34% |
| W | Wayfair Inc Class A | 0.32% |
| BMNR | BitMine Immersion Technologies Inc | 0.29% |
| AHR | American Healthcare REIT Inc Ordinary Shares | 0.28% |
| BTSG | BrightSpring Health Services Inc | 0.27% |
| R | Ryder System Inc | 0.26% |
| VSAT | Viasat Inc | 0.26% |
| ENSG | Ensign Group Inc | 0.25% |
| WTFC | Wintrust Financial Corp | 0.25% |
Sector breakdown · SCHA
Real Estate6.9%
Consumer Cyclical11.1%
Basic Materials4.2%
Consumer Defensive2.9%
Technology15.1%
Communication Services2.8%
Financial Services16.9%
Utilities2.5%
Industrials14.5%
Energy5.8%
Healthcare17.3%
About BIL
BIL (SPDR Bloomberg 1-3 Month T-Bill ETF) is Ultra-short T-Bills, cash-equivalent. Managed by State Street, the fund carries $48.5B in assets under management, an expense ratio of 0.14%, a dividend yield of 3.66%.
About SCHA
SCHA (Schwab US Small-Cap ETF) is US small-cap equities. Managed by Schwab, the fund carries $22.0B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.12%. Its largest holding is Halozyme Therapeutics Inc (HALO), which represents 0.4% of the portfolio. Real Estate is the fund's largest sector exposure at 6.9%.